ANN ARBOR – The Cutting Edge, Drug Discovery and Development in Michigan Symposium Sept. 9-10 will showcase drug R&D activities at the state’s research universities and discuss the development, funding, partnering, and commercialization of new therapeutic discoveries.
The program is meant to bring together representatives from academia, industry, contract research organizations, funders, and others to talk about Michigan’s current drug discovery efforts and future capacity within an academic paradigm.
Changes in the pharmaceutical R&D business model coupled with an enhanced emphasis on federally funded translational research has given rise in the number and sophistication of academic drug discovery centers.
For more information, click on http://www.michbio.org/?page=ddagenda
Author: Staff Writer
Source: MichBio
Date: 7/9/2015
